Panacea Biotec - Quaterly Results

12 Nov 2021 Evaluate
A minor change in the total revenue was seen in the September 2021 quarter. The total revenue for the quarter stood at Rs. 1192.60 millions against Rs. 1182.00 millions during year ago period.The Net Loss for the quarter ended September 2021 is Rs. -223.70 millions as compared to Net Profit of Rs. 101.20 millions of corresponding quarter ended September 2020Operating profit Margin for the quarter ended September 2021 slipped to -139.80% as compared to 188.10% of corresponding quarter ended September 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 1192.60 1182.00 0.90 1555.20 1946.80 -20.12 3435.60 1580.90 117.32
Other Income 34.70 29.50 17.63 76.20 58.20 30.93 207.40 308.70 -32.82
PBIDT -139.80 188.10 -174.32 -292.40 191.60 -252.61 212.40 -313.50 -167.75
Interest 19.10 19.90 -4.02 36.90 37.70 -2.12 75.20 52.70 42.69
PBDT -158.90 168.20 -194.47 -329.30 153.90 -313.97 137.20 -520.20 -126.37
Depreciation 64.80 66.90 -3.14 129.10 133.60 -3.37 265.70 269.10 -1.26
PBT -223.70 101.30 -320.83 -458.40 20.30 -2358.13 -128.50 -789.30 -83.72
TAX 0.00 0.10 0.00 0.00 0.30 0.00 15.60 171.00 -90.88
Deferred Tax 0.00 0.10 0.00 0.00 0.30 0.00 -7.10 -227.80 -96.88
PAT -223.70 101.20 -321.05 -458.40 20.00 -2392.00 -144.10 -960.30 -84.99
Equity 61.30 61.30 0.00 61.30 61.30 0.00 61.30 61.30 0.00
PBIDTM(%) -11.72 15.91 -173.66 -18.80 9.84 -291.04 6.18 -19.83 -131.18

Panacea Biotec Share Price

407.05 48.55 (13.54%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×